These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 5742338)

  • 21. Study of the antigenic structure of Coxiella burneti. VI. Chromatographic analysis of phase I antigen of C. burneti on DEAE-cellulose.
    Brezina R; Schramek S
    Acta Virol; 1968 Jan; 12(1):68-72. PubMed ID: 4384115
    [No Abstract]   [Full Text] [Related]  

  • 22. Study of the antigenic structure of Coxiella burneti. VII. Properties of phenol-extracted phase I antigenic component.
    Brezina R; Pospísil V; Schramek S
    Acta Virol; 1970 Jul; 14(4):295-301. PubMed ID: 4394184
    [No Abstract]   [Full Text] [Related]  

  • 23. THE INFLUENCE OF PHASE ON THE PROTECTIVE POTENCY OF Q FEVER VACCINE.
    ORMSBEE RA; BELL EJ; LACKMAN DB; TALLENT G
    J Immunol; 1964 Mar; 92():404-12. PubMed ID: 14128986
    [No Abstract]   [Full Text] [Related]  

  • 24. [Q fever in cows with special reference to Coxiella burnetii colonization of the udder].
    Moretti B
    Ann Ist Super Sanita; 1984; 20(4):317-27. PubMed ID: 6400460
    [No Abstract]   [Full Text] [Related]  

  • 25. [The dynamics of the morphological changes in the tissues after the subcutaneous administration of vaccines against Q fever].
    Resl M; Vasilenko AZh; Lesný M; Propper P
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jan; (1):40-3. PubMed ID: 1858470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experience with simultaneous immunization of the population with live vaccines against brucellosis and Q-fever].
    Kniazeva EN; Genig VA; Beletskaia GA; Voshchakina NV; Egorova LS; Kostiukov VL; Panina NV; Tsel'nikov PS
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Jan; 46(1):112-7. PubMed ID: 5787559
    [No Abstract]   [Full Text] [Related]  

  • 27. Electron microscopic study in guinea-pig cells during infection or vaccination with Coxiella burneti.
    Dumitrescu S; Ionescu MD; Crăcea E; Petrovici A; Botez D; Ioanid L
    Arch Roum Pathol Exp Microbiol; 1975; 34(1-2):145-53. PubMed ID: 1212070
    [No Abstract]   [Full Text] [Related]  

  • 28. Phase II to phase I conversion of Coxiella burneti in immunosuppressed mice.
    Kazár J; Brezina R; Skultétyová E; Kovácová E; Schramek S
    Acta Virol; 1975 Jul; 19(4):359-63. PubMed ID: 241236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of a killed phase I Coxiella burnetii vaccine in cynomolgus monkeys (Macaca fascicularis).
    Kishimoto RA; Gonder JC; Johnson JW; Reynolds JA; Larson EW
    Lab Anim Sci; 1981 Feb; 31(1):48-51. PubMed ID: 7253550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of Q fever phase I corpuscular vaccine to influence the persistence and reactivation of Coxiella burnetii infection in mouse and guinea pig tissues.
    Kazár J; Kovácová E
    Acta Virol; 1983 Sep; 27(5):418-28. PubMed ID: 6139946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The antigenic properties of Rickettsia burneti from the collection of the division of especially dangerous infections of the Pasteur Institute].
    Amosenkova MI
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1970; 37():53-9. PubMed ID: 5537970
    [No Abstract]   [Full Text] [Related]  

  • 32. Dermal reactions and antibody responses in dairy cows and laboratory animals vaccinated with Coxiella burnetii.
    Biberstein EL; Crenshaw GL; Behymer DE; Franti CE; Bushnell RB; Riemann HP
    Cornell Vet; 1974 Jul; 64(3):387-406. PubMed ID: 4845729
    [No Abstract]   [Full Text] [Related]  

  • 33. [Attenuated variants of Rickettsia burneti and several prospects for their use in live vaccines against Q fever].
    Urakov NN; Gudima OS; Tereshchenko MO; Shchetinin VP; Shevyreva NA
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Feb; 43(2):143. PubMed ID: 6004845
    [No Abstract]   [Full Text] [Related]  

  • 34. [Current data on epidemiology and diagnosis of Q fever].
    Crăcea E; Dumitrescu S; Sabin S; Botez D; Ioanid L
    Microbiol Parazitol Epidemiol (Bucur); 1972; 17(5):395-402. PubMed ID: 4646610
    [No Abstract]   [Full Text] [Related]  

  • 35. AN ANTIGENIC ANALYSIS OF THREE STRAINS OF COXIELLA BURNETI.
    ORMSBEE RA; PICKENS EG; LACKMAN DB
    Am J Hyg; 1964 Mar; 79():154-62. PubMed ID: 14130309
    [No Abstract]   [Full Text] [Related]  

  • 36. Standardized guinea pig model for Q fever vaccine reactogenicity.
    Baeten LA; Podell BK; Sluder AE; Garritsen A; Bowen RA; Poznansky MC
    PLoS One; 2018; 13(10):e0205882. PubMed ID: 30312355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of local morphological changes after intradermal inoculation of Q-fever chemovaccine.
    Resl M; Sidorenko SV; Zhuljabin EI
    Acta Virol; 1989 Mar; 33(2):167-71. PubMed ID: 2569813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An antigenic comparison of strains of Coxiella burneti.
    Fiset P; Wike DA; Pickens EG; Ormsbee RA
    Acta Virol; 1971 Mar; 15(2):161-6. PubMed ID: 4396414
    [No Abstract]   [Full Text] [Related]  

  • 39. Protective immunity induced by 67 K outer membrane protein of phase I Coxiella burnetii in mice and guinea pigs.
    Zhang YX; Zhi N; Yu SR; Li QJ; Yu GQ; Zhang X
    Acta Virol; 1994 Dec; 38(6):327-32. PubMed ID: 7793356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A live vaccine 1-M-44 against Q-fever for oral use.
    Genig VA
    J Hyg Epidemiol Microbiol Immunol; 1968; 12(3):265-73. PubMed ID: 5753316
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.